Australia is closely awaiting the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://victorfrvg116288.birderswiki.com/2529718/novo_nordisk_s_retatrutide_australia_a_new_solution_for_obesity_treatment